Seer Inc. is a life sciences company founded in 2017 and headquartered in Redwood City, California, United States. The company specializes in developing innovative solutions for proteomics research. Proteomics is the study of proteins and their functions within living organisms, and Seer aims to enable researchers and scientists to gain deeper insights into biology and disease by advancing the field of proteomics.
Seer's primary focus is on developing its proprietary platform called Proteograph™, which combines mass spectrometry and data science to generate high-quality proteomic data. This data can be used by researchers across various fields, including oncology, neurology, and immunology, to study protein interactions and identify potential biomarkers for diseases. The company's technology and data-driven approach offer researchers a powerful tool to accelerate their discoveries and advance the understanding of complex biological processes.
Since its founding, Seer has been dedicated to pushing the boundaries of proteomics research and technology. The company has assembled a team of talented scientists, researchers, and data experts who work together to develop and refine their innovative platform. Seer's commitment to advancing the field of proteomics has gained recognition in the scientific community, and it continues to collaborate with leading academic institutions and research organizations to further expand its understanding of proteins and their role in health and disease.